Unknown

Dataset Information

0

Persistence of adoptively transferred T cells with a kinetically engineered IL-2 receptor agonist.


ABSTRACT: Interleukin-2 (IL-2) is a component of most protocols of adoptive cell transfer (ACT) therapy for cancer, but is limited by short exposure and high toxicities. NKTR-214 is a kinetically-engineered IL-2 receptor ?? (IL-2R??)-biased agonist consisting of IL-2 conjugated to multiple releasable polyethylene glycol chains resulting in sustained signaling through IL-2R??. We report that ACT supported by NKTR-214 increases the proliferation, homing and persistence of anti-tumor T cells compared to ACT with IL-2, resulting in superior antitumor activity in a B16-F10 murine melanoma model. The use of NKTR-214 increases the number of polyfunctional T cells in murine spleens and tumors compared to IL-2, and enhances the polyfunctionality of T and NK cells in the peripheral blood of patients receiving NKTR-214 in a phase 1 trial. In conclusion, NKTR-214 may have the potential to improve the antitumor activity of ACT in humans through increased in vivo expansion and polyfunctionality of the adoptively transferred T cells.

SUBMITTER: Parisi G 

PROVIDER: S-EPMC6994533 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications


Interleukin-2 (IL-2) is a component of most protocols of adoptive cell transfer (ACT) therapy for cancer, but is limited by short exposure and high toxicities. NKTR-214 is a kinetically-engineered IL-2 receptor βγ (IL-2Rβγ)-biased agonist consisting of IL-2 conjugated to multiple releasable polyethylene glycol chains resulting in sustained signaling through IL-2Rβγ. We report that ACT supported by NKTR-214 increases the proliferation, homing and persistence of anti-tumor T cells compared to ACT  ...[more]

Similar Datasets

2019-08-07 | GSE118748 | GEO
| S-EPMC3572023 | biostudies-literature
| S-EPMC6829590 | biostudies-literature
| S-EPMC6167529 | biostudies-literature
| S-EPMC3383803 | biostudies-literature
| PRJNA486672 | ENA
| S-EPMC3048898 | biostudies-literature
| S-EPMC5674950 | biostudies-literature
| S-EPMC3004157 | biostudies-literature
| S-EPMC6238208 | biostudies-literature